agilon health (NYSE:AGL) Sets New 52-Week Low After Analyst Downgrade

agilon health, inc. (NYSE:AGL) shares hit a new 52-week low during mid-day trading on Thursday after Citigroup lowered their price target on the stock from $2.50 to $1.75. Citigroup currently has a sell rating on the stock. agilon health traded as low as $1.75 and last traded at $1.77, with a volume of 249680 shares traded. The stock had previously closed at $1.88.

Other research analysts have also recently issued reports about the stock. William Blair cut shares of agilon health from an “outperform” rating to a “market perform” rating in a report on Friday, November 8th. Barclays decreased their target price on shares of agilon health from $5.00 to $2.00 and set an “underweight” rating for the company in a report on Monday, November 11th. TD Cowen decreased their target price on shares of agilon health from $6.00 to $2.00 and set a “hold” rating for the company in a report on Monday, November 11th. Evercore ISI decreased their target price on shares of agilon health from $7.00 to $4.00 and set an “in-line” rating for the company in a report on Tuesday, October 8th. Finally, Stifel Nicolaus decreased their target price on shares of agilon health from $7.00 to $2.00 and set a “hold” rating for the company in a report on Tuesday. Three equities research analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $6.38.

Insider Buying and Selling at agilon health

In other agilon health news, CEO Steven Sell bought 20,000 shares of agilon health stock in a transaction on Thursday, September 12th. The stock was purchased at an average cost of $3.36 per share, for a total transaction of $67,200.00. Following the completion of the purchase, the chief executive officer now directly owns 67,590 shares of the company’s stock, valued at $227,102.40. The trade was a 42.03 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 3.20% of the company’s stock.

Hedge Funds Weigh In On agilon health

Institutional investors have recently modified their holdings of the company. Vanguard Group Inc. raised its position in shares of agilon health by 1.3% in the first quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company’s stock valued at $176,582,000 after purchasing an additional 371,537 shares during the period. AQR Capital Management LLC increased its position in agilon health by 3,338.5% during the second quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock worth $8,871,000 after acquiring an additional 1,316,990 shares during the period. Susquehanna Fundamental Investments LLC increased its position in agilon health by 65.0% during the second quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company’s stock worth $5,262,000 after acquiring an additional 316,856 shares during the period. Capital International Investors increased its position in agilon health by 84.7% during the first quarter. Capital International Investors now owns 20,197,932 shares of the company’s stock worth $123,207,000 after acquiring an additional 9,263,296 shares during the period. Finally, Simplicity Wealth LLC increased its position in agilon health by 145.1% during the second quarter. Simplicity Wealth LLC now owns 26,210 shares of the company’s stock worth $171,000 after acquiring an additional 15,515 shares during the period.

agilon health Price Performance

The stock’s 50-day moving average is $3.05 and its 200-day moving average is $4.86. The firm has a market cap of $653.05 million, a P/E ratio of -1.69 and a beta of 0.60. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06.

agilon health (NYSE:AGL) last announced its earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The company had revenue of $1.45 billion for the quarter, compared to the consensus estimate of $1.47 billion. During the same period last year, the firm posted ($0.06) EPS. As a group, equities analysts anticipate that agilon health, inc. will post -0.43 EPS for the current fiscal year.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.